With a 90% confidence rate, reducing doubts among family doctors and delays in diagnosis are the main objectives of the "Dermamatica" technology, which may be implemented in Portugal.

When a patient suspects that a skin lesion may be skin cancer , they are usually evaluated by a family doctor, who can rule out a high-risk case.

To reduce potential medical uncertainty and diagnostic delays, the “Dermamatica” project was created . Renascença spoke with one of the platform's four creators, Sam Izadloo, an Iranian researcher and medical student at Universidade Católica Portuguesa.

With an original algorithm and database built in Portugal, this technology uses artificial inteligence to detect melanomas and is planned to be a medical device used in local health units in Portugal.

Is a single photograph enough to diagnose melanoma?

When a mole is photographed, the “Dermamatica” generates a score, accompanied by a heat map showing potential treatment points.

With a 90% confidence level , the project explains to the doctor the specific characteristics that motivate the result, without necessarily being a "positive" or "negative" result.

“We don’t say whether the lesions are malignant or benign, but we help classify them and explain why they are a high-risk or low-risk sign,” Sam Izadloo, one of the four creators of the platform, explained to Renascença .

(...)

You can read the full article at Renascença.